Mutation spectrum and predicted function of laforin in Lafora's progressive myoclonus epilepsy

Neurology

Volumn 55, Issue 3, 2000, Pages 341-346

  Minassian, B A ^a,b   Ianzano, L ^a,b   Meloche, M ^a   Andermann, E ^c,d   Rouleau, G A ^d,e   Delgado Escueta, A V ^f   Scherer, S W ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e MONTREAL GENERAL HOSPITAL   (Canada)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLUCOSIDASE; LAFORIN; PROTEIN; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CELLULAR DISTRIBUTION; CHILD; EPILEPSY; FAMILY STUDY; GENE MUTATION; HUMAN; MYOCLONUS EPILEPSY; NERVE CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN STRUCTURE; SEIZURE;

EID: 0033842001     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.55.3.341     Document Type: Article

References (27)

1. Lafora's disease; distinct clinico-pathologic form of Unverricht's syndrome
2. Beitrag zur histopathologie der myoklonischen epilepsie
3. Studies in myoclonus epilepsy (Lafora body form); II. Polyglucosans in the systemic deposits of myoclonus epilepsy and in corpora amylacea
4. Monoclonal antibody against polyglucosan isolated from the myocardium of a patient with Lafora disease
5. Studies in myoclonus epilepsy. III. The effects of amylolytic enzymes on the ultrastructure of Lafora bodies
6. Corpora-amylacea and the family of polyglucosan diseases
7. Mutations in a gene encoding a novel protein tyrosine phosphatase causes progressive myoclonus epilepsy
8. Genetic locus heterogeneity in Lafora's progressive myoclonus epilepsy
9. Isolation and characterization of mouse homologue for the human epilepsy gene, EPM2A
10. Combining hydrophobicity and helicity: A novel approach to membrane protein structure prediction
11. Import of proteins into peroxisomes
12. Nucleocytoplasmic transport: Signals, mechanisms and regulation
13. Protein import into mitochondria
14. Pfam 3.1: 1313 Multiple alignments match the majority of proteins
15. The PROSITE database, its status in 1999
16. New deletion mutations in EPM2A and the genetic diagnosis of Lafora's disease
17. From form to function: Signaling by protein tyrosine phosphatases
18. Crystal structure of the MAPK phosphatase Pyst1 catalytic domain and implications for regulated activation
19. The 'VH1-like' dual-specificity protein tyrosine phosphatases
20. Specificity of the binding domain of glucoamylase 1
21. Raw-starch-digesting and thermostable α-amylase from the yeast cryptococcus sp. S-2: Purification, characterization, cloning and sequencing
22. Updating the sequence-based classification of glycosyl hydrolases
23. Structure and function of proteins of the phosphotransferase system and of 6-phospho-beta-glycosidases in gram-positive bacteria
24. The evolution of starch-binding domain
25. Glutamic acid 274 is the nucleophile in the active site of a 'retaining' exoglucanase from Cellulomonas fimi
26. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-triphosphate and Akt/protein kinase B signaling pathway
27. Human PIR1 of the protein-tyrosine phosphatase superfamily has RNA 5'-triphosphatase and diphosphatase activities